Arlinking Ong-Go, Personal communication (interview), April 13, 2023 Philippine Society of Gastroenterology, Mission and Vision, Accessed April 13, 2023 Philippine Food and Drug Administration, Nekothione, Nov
Similarly, the substudy of the obesity phase 2 trial showed clear promise for retatrutide in the treatment of MASLD [47], and through its GCG receptor agonism, retatrutide may offer benefits beyond WL, through weight-independent metabolic effects at the liver [40]
Just honest insight into whether compounded semaglutide is worth considering, how it works in real life, and what you should realistically expect before starting a GLP-1 weight-loss program
Ongoing evaluation by your healthcare provider will determine the duration of treatment based on your progress and health status